True Leaf Pet is a division of True Leaf Medicine International Ltd.  Visit www.trueleaf.com for more info.

True Leaf Completes Purchase of Award-Winning Animal-Care Product Company

January 09, 2017

True Leaf Completes Purchase of Award-Winning Animal-Care Product Company

OregaPet® purchase adds access to natural grocery shelves and revenue to the True Leaf bottom line
 
Vancouver, January 9, 2017 - True Leaf Pet Inc., the Vernon, BC company that produces and sells hemp-based functional chews for dogs, has completed the purchase of the assets and intellectual property of OregaPet®, an award-winning Canadian brand of medicinal products for animals.
 

Previously, True Leaf and OregaPet® announced the signing of a letter of intent on November 03, 2016. The purchase is now complete effective January 1st 2017, with True Leaf acquiring all of OregaPet®’s assets.

 
“This is a major positive step forward for True Leaf Pet,” said Darcy Bomford, True Leaf CEO. “The OregaPet® brand and natural-remedy focus align perfectly with our company’s “Quality of Life” vision for our customers and their pets. At the same time, the addition of 10 new items to our product line-up will instantly expand our in-store presence and generate revenue in all of our markets.”
 
True Leaf Pet paid a total of $200,000 – $100,000 in cash and $100,000 in shares – for the brand assets, and then agreed to pay $146,409.95 for finished goods and packaging inventory over three years with no interest. The seller and its principal shareholder, TLM Development Ltd., also agreed to enter into a 5-year non-competition and non-solicitation agreement covering pet-related businesses.
 
OregaPet®’s product line has attracted industry recognition for its innovation and effectiveness. OregaPet® Bed and Body Spray received the 2016 National Nutrition.ca award for Best Pet Product and OregaPet® Oil of Oregano received the 2013 Alive® Consumer’s Choice Silver Award for Best New Product.  Sales of OregaPet® products in Canada are approximately $12,000 per month, and the company expects significant growth as it rebrands the line for sale in the US and European specialty pet and natural grocery markets.  
 
“OregaPet is unique in that it is the only brand that has leveraged the widely-recognized medicinal powers of ‘oil of oregano’ and incorporated them into a pet product line.  Natural remedies and holistic alternatives to pharmaceuticals are top-of-mind with our customer demographic and we see a real winner here,” said True Leaf CEO, Darcy Bomford.
 
True Leaf has seen steady growth over the past quarter and expects solid performance as it enters the new year and closes off its fiscal year in March 2017. Key to the company’s strategy are additional line extensions under its successfully established ‘True Hemp’ brand and new product offerings through acquisitions and entries into new market segments.  
 
About True Leaf: True Leaf Medicine International Ltd., through its wholly-owned subsidiary ‘True Leaf Pet’, has entered the $104.9 billion global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada, the United States and Europe. The company has also filed an application under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) to become a Canadian licensed producer through its ‘True Leaf Medicine’ subsidiary. It has passed through the preliminary and enhanced screening process of Health Canada’s review and is currently awaiting security clearance and ‘pre-licensing inspection’ approval.
 
Media Contact:
Paul Sullivan
BreakThrough Communications
O: 604-685-4742
M: 604-603-7358
 
Investor Contact:
Kevin Bottomley
Director and Corporate Relations
M: 778-389-9933
E: kevin@trueleaf.com



Also in News

True Leaf Announces First Tranche Closing of Private Placement and Stock Option Grants
True Leaf Announces First Tranche Closing of Private Placement and Stock Option Grants

May 30, 2017

True Leaf Medicine International Ltd. (the "Company") (MJ: CSE)(TLA: FSE) is pleased to announce that it has closed the first tranche of its recently-announced non-brokered private placement...

Continue Reading

TRUE LEAF ANNOUNCES PRIVATE PLACEMENT
TRUE LEAF ANNOUNCES PRIVATE PLACEMENT

May 03, 2017

Vancouver, BC, May 3, 2017 – True Leaf Medicine International Ltd. (the "Company") (MJ: CSE)(TLA: FSE) is pleased to announce that it intends to complete a non-brokered private placement...

Continue Reading

Cannabis Experts Join True Leaf Team for Final Marijuana Licensing Review Stage
Cannabis Experts Join True Leaf Team for Final Marijuana Licensing Review Stage

April 23, 2017

True Leaf Medicine International Ltd. (CSE: MJ, FSE: TLA), has engaged a number of cannabis experts to guide the company through the final stages in Health Canada’s review of its application for a license to produce marijuana in Canada.

Continue Reading